A systematic review of the safety of probioticsDIDARI, Tina; SOLKI, Sara; MOZAFFARI, Shilan et al.Expert opinion on drug safety. 2014, Vol 13, Num 2, pp 227-239, issn 1474-0338, 13 p.Article

Acute mycophenolate overdose: case series and systematic literature analysisCESCHI, Alessandro; GREGORIANO, Claudia; RAUBER-LÜTHY, Christine et al.Expert opinion on drug safety. 2014, Vol 13, Num 5, pp 525-534, issn 1474-0338, 10 p.Article

An evidence based systematic review of remifentanil associated opioid-induced hyperalgesiaRIVOSECCHI, Ryan M; RICE, Mark J; SMITHBURGER, Pamela L et al.Expert opinion on drug safety. 2014, Vol 13, Num 5, pp 587-603, issn 1474-0338, 17 p.Article

Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studiesSALVO, Francesco; ANTONIAZZI, Stefania; MAI DUONG et al.Expert opinion on drug safety. 2014, Vol 13, Num 5, pp 573-585, issn 1474-0338, 13 p.Article

Drug-induced photoallergic and phototoxic reactions - an updateSCHEINFELD, Noah S; CHERNOFF, Karen; MAN KIN DEREK HO et al.Expert opinion on drug safety. 2014, Vol 13, Num 3, pp 321-340, issn 1474-0338, 20 p.Article

Drug―drug interaction between NSAIDS and low-dose aspirin: a focus on cardiovascular and GI toxicityNALAMACHU, Srinivas; PERGOLIZZI, Joseph V; RAFFA, Robert B et al.Expert opinion on drug safety. 2014, Vol 13, Num 7, pp 903-917, issn 1474-0338, 15 p.Article

Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertensionDINGEMANSE, Jasper; SIDHARTA, Patricia N; MADDREY, Willis C et al.Expert opinion on drug safety. 2014, Vol 13, Num 3, pp 391-405, issn 1474-0338, 15 p.Article

Factors affecting patient's perception of anticancer treatments side-effects: an observational studyRUSSO, Stefania; CINAUSERO, Marika; GERRATANA, Lorenzo et al.Expert opinion on drug safety. 2014, Vol 13, Num 2, pp 139-150, issn 1474-0338, 12 p.Article

Pattern and associated factors of anti-hepatitis C virus treatment-induced adverse reactionsRAVI, Saeedeh; NASIRI-TOOSI, Mohsen; KARIMZADEH, Iman et al.Expert opinion on drug safety. 2014, Vol 13, Num 3, pp 277-286, issn 1474-0338, 10 p.Article

Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patientsPEREZ-LLORET, Santiago; REY, María Verónica; CRISPO, James et al.Expert opinion on drug safety. 2014, Vol 13, Num 3, pp 351-360, issn 1474-0338, 10 p.Article

Risk versus risk: a review of benzodiazepine reduction in older adultsPAQUIN, Allison M; ZIMMERMAN, Kristin; RUDOLPH, James L et al.Expert opinion on drug safety. 2014, Vol 13, Num 7, pp 919-934, issn 1474-0338, 16 p.Article

Targeting the epidermal growth factor receptor in solid tumors: focus on safetyLUCCHINI, Eleonora; PILOTTO, Sara; SPADA, Elisa et al.Expert opinion on drug safety. 2014, Vol 13, Num 5, pp 535-549, issn 1474-0338, 15 p.Article

Understanding the safety and tolerability of facial filling therapeuticsKULICHOVA, Daniela; BOROVAYA, Alyona; RUZICKA, Thomas et al.Expert opinion on drug safety. 2014, Vol 13, Num 9, pp 1215-1226, issn 1474-0338, 12 p.Article

A review of the efficacy and safety of oral antidiabetic drugsSTEIN, Stephanie Aleskow; LAMOS, Elizabeth Mary; DAVIS, Stephen N et al.Expert opinion on drug safety. 2013, Vol 12, Num 2, pp 153-175, issn 1474-0338, 23 p.Article

Drug safety evaluation of vemurafenib in the treatment of melanomaTSAI, Kenneth Y; NOWROOZI, Sasan; KIM, Kevin B et al.Expert opinion on drug safety. 2013, Vol 12, Num 5, pp 767-775, issn 1474-0338, 9 p.Article

Potential nephroprotective effects of L-carnitine against drug-induced nephropathy: a review of literatureJAFARI, Atefeh; DASHTI-KHAVIDAKI, Simin; KHALILI, Hossein et al.Expert opinion on drug safety. 2013, Vol 12, Num 4, pp 523-543, issn 1474-0338, 21 p.Article

Safety evaluation of desloratadine in allergic rhinitisGONZALEZ-NUNEZ, Vanesa; VALERO, Antonio; MULLOL, Joaquim et al.Expert opinion on drug safety. 2013, Vol 12, Num 3, pp 445-453, issn 1474-0338, 9 p.Article

Safety of posaconazoleJACINTO, Pauline L; CHANDRASEKAR, Pranatharthi.Expert opinion on drug safety. 2013, Vol 12, Num 2, pp 265-274, issn 1474-0338, 10 p.Article

Testosterone exposure in childhood: discerning pathology from physiologyCABRERA, Susanne M; ROGOL, Alan D.Expert opinion on drug safety. 2013, Vol 12, Num 3, pp 375-388, issn 1474-0338, 14 p.Article

The controversy of a wider statin utilization: why?MANSI, Ishak; MORTENSEN, Eric.Expert opinion on drug safety. 2013, Vol 12, Num 3, pp 327-337, issn 1474-0338, 11 p.Article

The in vitro and in vivo effects of nicotine on bone, bone cells and fracture repairKALLALA, Rami; BARROW, Jonathan; GRAHAM, Simon Matthew et al.Expert opinion on drug safety. 2013, Vol 12, Num 2, pp 209-233, issn 1474-0338, 25 p.Article

Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin BLOO, Angela S; MUHSIN, Saif A; WALSH, Thomas J et al.Expert opinion on drug safety. 2013, Vol 12, Num 6, pp 881-895, issn 1474-0338, 15 p.Article

Agomelatine in depressionSMERALDI, Enrico; DELMONTE, Dario.Expert opinion on drug safety. 2013, Vol 12, Num 6, pp 873-880, issn 1474-0338, 8 p.Article

A comparison of pregnancy prevention programmes in EuropeCRIJNS, Ineke; ZOMERDIJK, Inge; STURKENBOOM, Miriam et al.Expert opinion on drug safety. 2014, Vol 13, Num 4, pp 411-420, issn 1474-0338, 10 p.Article

A drug safety evaluation of rituximab and risk of hepatitis BRIEDELL, Peter; CARSON, Kenneth R.Expert opinion on drug safety. 2014, Vol 13, Num 7, pp 977-987, issn 1474-0338, 11 p.Article